Literature DB >> 16272191

New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').

Fabrizio Schifano1, Paolo Deluca, Lisa Agosti, Giovanni Martinotti, John M Corkery, Baldacchino Alex, Bonan Caterina, Bothas Heikki, Brigada Raffaella, Comacchio Anna, Di Furia Lucia, Duarte Rui Eastwood Dorte, Farré Magi, Ferreira Susana, Flores Irene, Guionnet Claude, Harder Lisbet, Stokholm Jensen Lene, Leoni Mauro, Littlejohn Christopher, Majava Aino, Peltoniemi Teuvo, Pizza Milena, Rawaf Salman, Robert Damien, Rossi Maria Angela, Rovetto Francesco, Scherbaum Norbert, Siemann Holger, Tarrago Josep, Torrens Marta, Zambello Francesco.   

Abstract

2C-T-7 ('Blue Mystic'), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first synthesized in 1986; its desired effects include both a sense of empathy and of well-being. Hallucinations, nausea, anxiety, panic attacks and paranoid ideation are anecdotally reported. According to the different European sources here approached, the availability of 2C-T-7 at street level seems to be currently very low, although one death related to a mono-intoxication with 2C-T-7 has been documented in the USA. With respect to information on 2C-T-7 available online, due to both redundancy and relevance issues the initial identified sample of 360 was reduced to 118 websites. In 14 (11.9%) websites, the detailed description of the 2C-T-7 synthesis was given. Harm Reduction websites appeared significantly earlier in the search engines results' list than Anti drugs (p 0.006) websites. Five (4.2%) websites apparently offered 2C-T-7 for sale. The large body of knowledge available online seems to contrast with small numbers of seizures at street level; an exhaustive web mapping of drug-related issues may be of interest for the clinician. Projects aimed at designing more 'attractive' prevention websites should be planned and future studies should better assess the characteristics of those consumers who take advantage of the online information of hallucinogenic compounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272191     DOI: 10.1177/0269881105056660

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  12 in total

1.  Performance-enhancing drugs on the web: a growing public-health issue.

Authors:  Brian P Brennan; Gen Kanayama; Harrison G Pope
Journal:  Am J Addict       Date:  2013-02-01

2.  Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients.

Authors:  Giovanni Martinotti; Attilio Negri; Stefania Schiavone; Chiara Montemitro; Chiara Vannini; Gaia Baroni; Mauro Pettorruso; Fabio De Giorgio; Raffaele Giorgetti; Valeria Verrastro; Luigia Trabace; Andres Garcia; Ivan Castro; Juan Iglesias Lopez; Cristina Merino Del Villar; Fabrizio Schifano; Massimo di Giannantonio
Journal:  Front Psychiatry       Date:  2020-08-31       Impact factor: 4.157

Review 3.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

Review 4.  Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy.

Authors:  Manuela Graziani; Robert Nisticò
Journal:  Front Pharmacol       Date:  2015-06-09       Impact factor: 5.810

Review 5.  Sexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba.

Authors:  Ornella Corazza; Giovanni Martinotti; Rita Santacroce; Eleonora Chillemi; Massimo Di Giannantonio; Fabrizio Schifano; Selim Cellek
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

6.  Novel psychoactive substances and behavioral addictions.

Authors:  Giovanni Martinotti; Ornella Corazza; Sophia Achab; Zsolt Demetrovics
Journal:  Biomed Res Int       Date:  2014-12-28       Impact factor: 3.411

Review 7.  Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.

Authors:  Giovanni Martinotti; Rita Santacroce; Mauro Pettorruso; Chiara Montemitro; Maria Chiara Spano; Marco Lorusso; Massimo di Giannantonio; Arturo G Lerner
Journal:  Brain Sci       Date:  2018-03-16

8.  Suicidal Behavior and Club Drugs in Young Adults.

Authors:  Giovanni Martinotti; Stefania Schiavone; Attilio Negri; Chiara Vannini; Luigia Trabace; Domenico De Berardis; Mauro Pettorruso; Stefano L Sensi; Massimo Di Giannantonio
Journal:  Brain Sci       Date:  2021-04-12

Review 9.  Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.

Authors:  Bernardo Dell'Osso; Umberto Albert; Anna Rita Atti; Claudia Carmassi; Giuseppe Carrà; Fiammetta Cosci; Valeria Del Vecchio; Marco Di Nicola; Silvia Ferrari; Arianna Goracci; Felice Iasevoli; Mario Luciano; Giovanni Martinotti; Maria Giulia Nanni; Alessandra Nivoli; Federica Pinna; Nicola Poloni; Maurizio Pompili; Gaia Sampogna; Ilaria Tarricone; Sarah Tosato; Umberto Volpe; Andrea Fiorillo
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-30       Impact factor: 2.570

10.  Substance use in the club scene of Rome: a pilot study.

Authors:  Alessandro Emiliano Vento; Giovanni Martinotti; Eduardo Cinosi; Matteo Lupi; Tiziano Acciavatti; Dario Carrus; Rita Santacroce; Eleonora Chillemi; Ludovica Bonifaci; Massimo di Giannantonio; Ornella Corazza; Fabrizio Schifano
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.